Wegovy
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
Micheal
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. ...
Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says
Micheal
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication ...
Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints
Micheal
Shares in Novo Nordisk plunged 20% on Friday. Read More
